Mirae Asset Global Investments
FLNA

Mirae Asset Global Investments’s Filana Therapeutics FLNA Stock Holding History

Mirae Asset Global Investments’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,475
Closed -$387K – 2337
2024
Q1 		$387K Sell
16,475
-1,418
-8% -$32.7K ﹤0.01% 2007
2023
Q4 		$403K Buy
17,893
+1,418
+9% +$30K ﹤0.01% 2072
2023
Q3 		$274K Hold
16,475
– – ﹤0.01% 2170
2023
Q2 		$404K Hold
16,475
– – ﹤0.01% 2042
2023
Q1 		$397K Hold
16,475
– – ﹤0.01% 2035
2022
Q4 		$487K Hold
16,475
– – ﹤0.01% 1910
2022
Q3 		$689K Buy
16,475
+4,930
+43% +$133K ﹤0.01% 1692
2022
Q2 		$325K Buy
+11,545
New +$292K ﹤0.01% 1948

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mirae Asset Global Investments's FLNA Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Filana Therapeutics (FLNA) in Q2 2024, closing a stake of 16,475 shares — an estimated $387K sold.

Mirae Asset Global Investments first reported a position in FLNA in Q2 2022 and held it in 8 quarters. The position peaked at $689K in Q3 2022. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Filana Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 16,475 Filana Therapeutics shares in Q2 2024, an estimated $387K.
  • Mirae Asset Global Investments first reported a position in Filana Therapeutics in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Filana Therapeutics position peaked at $689K in Q3 2022.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.